| abstract |
This invention relates to compounds of formula (see formula I) in which one of R6, R7 and R8 is (see formula), and X of Y1 to Y4, R1 to R14. and n have the meanings defined in the description and all enantiomers and pharmaceutically acceptable salts and / or esters thereof. The invention also relates to pharmaceutical compositions containing the compounds, to a process during their obtaining and to the use thereof for the treatment and / or prevention of diseases that are modulated by PPAR (and / or PPAR agonists). |